Skip to content

Lumefantrine

Antimalarial — ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS

Also known as: benflumelol, benflumetol

OfpFDA approvedOrphan designationATC P01BF01

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Lumefantrine is an ofp drug in the Antimalarial class catalogued in DrugCentral. It was first approved by the FDA in 2009. DrugCentral lists 1 molecular target, including KCNH2. Recorded indications include Falciparum malaria.

  • Approval status: ofp (first approved 2009 by the FDA).
  • Drug class: Antimalarial.
  • Molecular targets: KCNH2 (1 listed in DrugCentral).
  • Indications: Falciparum malaria.
  • ATC code: P01BF01 (Artemisinin and derivatives, combinations).
  • Molecular formula: C30H32Cl3NO; molecular weight 528.94 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

  • Falciparum malaria

Contraindications (6)

  • Bradycardia
  • Congenital long QT syndrome
  • Hypokalemia
  • Hypomagnesemia
  • Prolonged QT interval
  • Torsades de pointes

Mechanism & targets

Established pharmacologic classAntimalarial

Molecular targets (1)

TargetGeneActionActivity
Potassium voltage-gated channel subfamily H member 2KCNH2unknownIC50 5.09

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
2009-04-07FDA—NOVARTISYes

ATC classification

ATC codeTherapeutic hierarchy
P01BF01ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS › ANTIPROTOZOALS › ANTIMALARIALS › Artemisinin and derivatives, combinations

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Lumefantrine is on its molecule page.

Molecular formulaC30H32Cl3NO
Molecular weight528.94 g/mol
CAS number82186-77-4
InChIKeyDYLGFOYVTXJFJP-MYYYXRDXSA-N
PubChem CID6437380
CCCCN(CCCC)CC(O)C1=CC(Cl)=CC2=C1C1=CC=C(Cl)C=C1\C2=C\C1=CC=C(Cl)C=C1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Lumefantrine used for?

DrugCentral lists the following indications for Lumefantrine: Falciparum malaria.

How does Lumefantrine work?

Its molecular targets in DrugCentral include KCNH2.

When was Lumefantrine first approved?

Lumefantrine was first approved by the FDA in 2009.

What drug class does Lumefantrine belong to?

Lumefantrine is in the Antimalarial class.

What is the chemical formula of Lumefantrine?

Lumefantrine has the molecular formula C30H32Cl3NO and a molecular weight of 528.94 g/mol.

Browse: all drugs starting with L · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

StatusOFP
First approval2009-04-07
AgencyFDA
Targets1
Indications1
FormulaC30H32Cl3NO
DrugCentral ID1617
Interactive profile